Hutchmed (china) Share Discussion Threads

[nerdofsteel] 02/6/2019 16:44

Our company has been nominated for awards in the following 2 categories at this years European Mediscience Awards:-



1. Breakthrough of the Year
2. Chief Executive of the Year

[nerdofsteel] 02/6/2019 13:13

Here is a great discussion on NSCLC and immunotherapies from this years ASCO - one of the panelists is Tony Mok, a Non-Exec Director at Chi-Med whom I have had the pleasure of meeting at the AGM

[nerdofsteel] 02/6/2019 09:06

apologies Lauders, I do read your posts but missed #1945 or have a very bad memory! Please do keep posting! ;o-)

ASCO2019 post session this afternoon, I suspect we will see some comments by the Oncology community later in the day

[lauders] 01/6/2019 16:50

Last two posts repeat what I posted in post #1945. Guess nobody reads LOL!

Never mind, think we all agree on HCM being higher in the future.

[waldron] 01/6/2019 08:25

Nerdofsteel
1 Jun '19 - 08:24 - 1949 of 1949
0 0 0
Trinity Delta issued an updated research note on Thursday



I continue to Buy


$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$


Hutchison China MediTech

Timing is right for a Hong Kong debut

Update | 30 May 2019

Share this note
AddThis Sharing Buttons
Share to Twitter
TwitterShare to LinkedIn
LinkedIn

Approval of EGM resolutions paves the way for the IPO of Hutchison China MediTech (Chi-Med) on the Hong Kong Stock Exchange (SEHK) in the coming months. This IPO should enhance Chi-Med’s access to capital, broaden its shareholder base, further raise its profile in its home market, and, importantly, improve liquidity. Liquidity will be further boosted by an associated global offering (size and structure are not yet disclosed), the secondary placement of shares by majority shareholder CK Hutchison Holdings Ltd, and a share split effective May 30th. Each ordinary AIM share is being divided into 10 new shares; an adjustment to the ADS ratio ensures there is no effect on the NASDAQ trading price. Accounting for this share split, our valuation remains $35.57/ADS ($4.74bn) but is now £5.47/share (£3.65bn) vs £54.72/share previously.

[nerdofsteel] 01/6/2019 08:24

Trinity Delta issued an updated research note on Thursday

hxxps://www.trinitydelta.org/research-notes/timing-is-right-for-a-hong-kong-debut/

I continue to Buy

[nerdofsteel] 01/6/2019 08:24

Agreed, I have been buying ADR's, also a bit of a currency play too

[dbadvn] 31/5/2019 09:10

SJ
Buy adrs. More liquidity less spread.

[steeplejack] 31/5/2019 08:27

10% nominal spread on the new share quote.Quite ridiculous.

[lauders] 30/5/2019 14:28

See Trinity Delta released this today:

Approval of EGM resolutions paves the way for the IPO of Hutchison China MediTech (Chi-Med) on the Hong Kong Stock Exchange (SEHK) in the coming months. This IPO should enhance Chi-Med’s access to capital, broaden its shareholder base, further raise its profile in its home market, and, importantly, improve liquidity. Liquidity will be further boosted by an associated global offering (size and structure are not yet disclosed), the secondary placement of shares by majority shareholder CK Hutchison Holdings Ltd, and a share split effective May 30th. Each ordinary AIM share is being divided into 10 new shares; an adjustment to the ADS ratio ensures there is no effect on the NASDAQ trading price. Accounting for this share split, our valuation remains $35.57/ADS ($4.74bn) but is now £5.47/share (£3.65bn) vs £54.72/share previously.

[lauders] 30/5/2019 11:12

Anyone looking at the chart today and not following the story will be in for a shock! Hope everyone is on the ball ;-) I will only be able to check what Selftrade did re: my account later when I finish work. Hope all is OK. They already contacted me twice to say that a split was going to take place.

[nerdofsteel] 30/5/2019 11:08

I am suffering from the usual dreadful AJ Bell platform, nothing updated and I cannot trade in HCM either. I will continue to buy ADR's.

[horburyjunction] 30/5/2019 10:21

Hamsterdam - You're lucky I use iiand mine aren't even showing

[shaker44] 30/5/2019 09:36

Iweb updated both share price and quantity simultaneously. Should be the norm surely

[steeplejack] 30/5/2019 09:24

Might be a day or two before Barclays updates in my experience.

[sportii] 30/5/2019 09:15

I have Barclays stockbrokers account-
1.yet to update number of shares.
2. Shows new share price. Hence, My portfolio valuation is showing ‘72% decline’!
3.One Good thing-buy price £4.75 an improvement of £2 compared to last night’s closing price £45.50.

[hamsterdam] 30/5/2019 08:32

My Interactive Investor account has now been updated. I now own 6910 shares, had 691 before.

[nerdofsteel] 30/5/2019 07:08

Hong Kong Stock Exchange 2nd Biotech Summit full stream is now available



You can select the sessions you wish to view

[nerdofsteel] 29/5/2019 12:16

Wonderfully efficient Company Secretary and NOMAD - RNS within an hour of today's meeting, I look forward to having an even larger number of shares at 8am in the morning!

I continue to Buy

[lauders] 29/5/2019 02:28

Thanks for the link JAF1969. Like this part:

This is the first time Hutchison has sold any shares but it has said that this does not mean any diminution of commitment — it is just that Chi-Med is now in a position to stand alone. Years ago it did the same thing with Orange, the telecoms company, when it propelled it to global leadership. Patient capital indeed.

The background to the offer is the bolstering of Hong Kong listing rules which increase the efficient access of growth capital for biotech companies in the region. This is among the first and although the Hong Kong listing has not yet been finalised, it is expected to be by the end of next month or the beginning of July.

The bottom line though is that there will be roughly $500 million of what is effectively new equity for institutional buyers, and as the shares will also retain their Aim listing, they will be traded on a 24-hour basis in America, Europe and Asia. So for many this will be the first time they will have been able to gather a meaningful stake in Chi-Med.

This part cannot be overlooked either:

But the point is that even if HSBC is wrong by half in its estimate of sales, and the drugs don’t fulfil their full potential, even on this basis the shares seem cheap.

[shaker44] 28/5/2019 18:20

Thanks. Well worth reading.

[jaf1969] 28/5/2019 17:50

Article from today's Evening Standard.https://www.standard.co.uk/business/hutchison-china-meditech-looks-like-a-healthy-bet-in-its-major-drugs-push-a4152891.html

[nerdofsteel] 26/5/2019 11:55

And here is the latest HKEX Biotech newsletter

A further 10 Biotech's are due to list in HK this year, a list that will probably grow

[nerdofsteel] 26/5/2019 11:55

An interesting article written by the CEO of the Hong Kong Stock Exchange, including some commentary on Biotech

Reflections on Our New Listing Regime, One Year On........

[nerdofsteel] 22/5/2019 07:45

I could not agree more DBADVN! The long term trend is certainly upwards, even with the occasional pipeline problem ;o-)